Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant

Noninvasive biomarkers are needed to monitor stable patients after kidney transplant (KT), because subclinical acute rejection (subAR), currently detectable only with surveillance biopsies, can lead to chronic rejection and graft loss. We conducted a multicenter study to develop a blood‐based molecu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Transplant
Autori principali: Friedewald, John J., Kurian, Sunil M., Heilman, Raymond L., Whisenant, Thomas C., Poggio, Emilio D., Marsh, Christopher, Baliga, Prabhakar, Odim, Jonah, Brown, Merideth M., Ikle, David N., Armstrong, Brian D., charette, jane I., Brietigam, Susan S., Sustento-Reodica, Nedjema, Zhao, Lihui, Kandpal, Manoj, Salomon, Daniel R., Abecassis, Michael M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6387870/
https://ncbi.nlm.nih.gov/pubmed/29985559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15011
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi